SORL1 mutations, occurring frequently in a subset of familial cases of Alzheimer’s disease (AD), have been documented, but their pathogenic potential is not yet clear and questions remain concerning their putative influence on the physiopathological processing of APP. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.